Skip to search.
 FTSE 100 Down 1.39%

Kite Pharma, Inc. (KITE)

-NasdaqGS
39.95 Down 1.52(3.67%) 8 Feb 21:00
Prev Close:41.47
Open:40.55
Bid:39.99 x 1000
Ask:40.14 x 200
1y Target Est:88.44
Beta:N/A
Earnings Date:24 Mar - 28 Mar (Est.)
Day's Range:38.72 - 42.43
52wk Range:38.72 - 89.84
Volume:1,173,757
Avg Vol (3m):1,213,500
Market Cap:1.90b
P/E (ttm):N/A
EPS (ttm):-1.81
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

  • No Headlines available for KITE at this time.

Comparison

Symbol% ChgMkt Cap
KITEDown 3.67%1.90b
PFEDown 1.62%176.32b
CELGUp 1.32%77.92b

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):148.10
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-2.15
Quarterly EPS Est (Dec-15) :-0.71
Mean Recommendation*:1.5
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Kite Pharma, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel cancer immunotherapy products. more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback